Cargando…
Accurate detection of early-stage lung cancer using a panel of circulating cell-free DNA methylation biomarkers
BACKGROUND: Lung cancer remains the leading cause of cancer mortality worldwide. Early detection of lung cancer helps improve treatment and survival. Numerous aberrant DNA methylations have been reported in early-stage lung cancer. Here, we sought to identify novel DNA methylation biomarkers that co...
Autores principales: | Hu, Shuo, Tao, Jinsheng, Peng, Minhua, Ye, Zhujia, Chen, Zhiwei, Chen, Haisheng, Yu, Haifeng, Wang, Bo, Fan, Jian-Bing, Ni, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134678/ https://www.ncbi.nlm.nih.gov/pubmed/37101220 http://dx.doi.org/10.1186/s40364-023-00486-5 |
Ejemplares similares
-
Predicting disease-free survival in colorectal cancer by circulating tumor DNA methylation markers
por: Yang, Xin, et al.
Publicado: (2022) -
Circulating cell-free DNA-based methylation patterns for breast cancer diagnosis
por: Zhang, Xianyu, et al.
Publicado: (2021) -
The Potential of Circulating Cell-Free DNA Methylation as an Epilepsy Biomarker
por: Martins-Ferreira, Ricardo, et al.
Publicado: (2022) -
Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA
por: Lanman, Richard B., et al.
Publicado: (2015) -
Diagnosis of pulmonary nodules by DNA methylation analysis in bronchoalveolar lavage fluids
por: Li, Lei, et al.
Publicado: (2021)